Epigenetic 'priming' boosts ovarian cancer immunotherapy
An epigenetic inhibitor can boost immune system activity in patients with ovarian cancer, making them more suitable for treatment with immunotherapy, according to a Northwestern Medicine study published in the Journal of ...
Jul 26, 2022
0
69